Home/Filings/4/0000950170-24-030457
4//SEC Filing

Varanakis Ann 4

Accession 0000950170-24-030457

CIK 0001845257other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 9:48 PM ET

Size

8.1 KB

Accession

0000950170-24-030457

Insider Transaction Report

Form 4
Period: 2024-03-08
Varanakis Ann
Chief People Officer
Transactions
  • Sale

    Common Stock

    2024-03-11$6.93/sh15,434$106,958268,276 total
  • Award

    Common Stock

    2024-03-08+83,217251,658 total
  • Award

    Common Stock

    2024-03-08+32,052283,710 total
Footnotes (3)
  • [F1]Includes 83,217 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024.
  • [F3]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Documents

1 file

Issuer

LifeStance Health Group, Inc.

CIK 0001845257

Entity typeother

Related Parties

1
  • filerCIK 0001965703

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 9:48 PM ET
Size
8.1 KB